Abstract Search

ea0035p18 | Adrenal cortex | ECE2014

Adrenal function in glucocorticoid-treated patients with acute exacerbations of COPD: the ‘REDUCE^*' randomized trial

Schuetz Philipp , Leuppi Joerg D , Bingisser Roland , Bodmer Michael , Briel Matthias , Drescher Tillman , Duerring Ursula , Henzen Christoph , Leibbrandt Yolanda , Maier Sabrina , Miedinger David , Muller Beat , Scherr Andreas , Schindler Christian , Stoeckli Rolf , Viatte Sebastien , von Garnier Christophe , Tamm Michael , Rutishauser Jonas

Introduction: Systemic glucocorticoid therapy may put patients at risk for later adrenal failure during times of stress, but tapering increases cumulative steroid exposure. We prospectively evaluated adrenal function and clinically relevant hypocortisolism after abruptly stopping prednisone treatment in patients with exacerbated COPD.Methods: This is a pre-specified analysis of the REDUCE randomized trial (Journal of American Medical Association...

0 shares

Endocrine Abstracts

Adrenal function in glucocorticoid-treated patients with acute exacerbations of COPD: the ‘REDUCE^*' randomized trial

BiosciAbstracts

Endocrine Abstracts

Adrenal function in glucocorticoid-treated patients with acute exacerbations of COPD: the ‘REDUCE*' randomized trial

BiosciAbstracts

Adrenal function in glucocorticoid-treated patients with acute exacerbations of COPD: the ‘REDUCE^*' randomized trial